Tech Company Financing Transactions
Topokine Therapeutics Funding Round
On 4/22/2016, Topokine Therapeutics landed $85 million in financing from .
Transaction Overview
Company Name
Announced On
4/22/2016
Transaction Type
Debt
Amount
$85,000,000
Round
Undisclosed
Investors
No investors have been recorded for this company.
Proceeds Purpose
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
60 South Street 1120
Boston, MA 02111
USA
Boston, MA 02111
USA
Phone
Website
Email Address
Overview
Topokine is a Boston-based, clinical-stage biotechnology company developing topical medications to contour the face and body non-invasively. Our initial focus is on facial aesthetics. Today, the only available therapies to contour the face and neck require cutting or puncturing the skin.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Murat Kalayoglu
Chief Scientific Officer
Michael Singer
Browse more venture capital transactions:
Prev: 4/22/2016: NurseGrid venture capital transaction
Next: 4/22/2016: Sysdig venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs